Follow us on LinkedIn
España
NTC
Novelty, Technology, Care
News & Events
-
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis- Jan 14, 2021
NTC, an international R&D focused pharmaceutical company headquartered in Italy,… -
New CE certifications for three NTC products based on tiab technology- Jul 22, 2020
NTC Srl, R&D focused pharmaceutical company headquartered in Italy, has… -
NTC grants license and distribution rights in Israel to Taro Pharmaceutical Industries- Jun 17, 2020
NTC Srl, an R&D focused pharmaceutical company headquartered in Italy,… -
NTC for Covid-19 emergency: our commitment is playing an active role to support community and raising awareness- Apr 30, 2020
The Covid-19 situation has been evolving: the responsibility of everyone…
PHARMACOVIGILANCE